Skip to main content
Fig. 2 | Cardio-Oncology

Fig. 2

From: Recurrent heart failure with preserved ejection fraction associated with carfilzomib administration for multiple myeloma

Fig. 2

Speckle tracking and strain measurements performed on transthoracic echocardiogram performed approximately 1 h after carfilzomib administration on the 1st day of 6th cycle of treatment. Panel (a): Speckle tracking measurements performed of the right ventricle with a longitudinal strain rate of − 33.1% (normal for age, gender and software). Panel (b): Polar map of left ventricular strain measurements of transthoracic echocardiography Speckle tracking measurements estimated a biplanar LV ejection fraction of 61% with normal strain values with a global longitudinal strain of − 22.5% (normal for age, gender and software)

Back to article page